A Tabula Rasa for pharmacy consulting

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

The drug is also approved to treat schizophrenia and bipolar depression.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.

Check out these important FDA updates from the month of October 2024.